MEDANTA - Swing Trade Analysis with AI Signals
Back to List📊 Swing Trade Rating: 3.9
| Stock Code | MEDANTA | Market Cap | 33,824 Cr. | Current Price | 1,258 ₹ | High / Low | 1,456 ₹ |
| Stock P/E | 68.2 | Book Value | 149 ₹ | Dividend Yield | 0.04 % | ROCE | 17.1 % |
| ROE | 13.2 % | Face Value | 2.00 ₹ | DMA 50 | 1,188 ₹ | DMA 200 | 1,178 ₹ |
| Chg in FII Hold | -0.39 % | Chg in DII Hold | 0.77 % | PAT Qtr | 124 Cr. | PAT Prev Qtr | 107 Cr. |
| RSI | 60.7 | MACD | 17.4 | Volume | 4,22,408 | Avg Vol 1Wk | 3,79,788 |
| Low price | 955 ₹ | High price | 1,456 ₹ | PEG Ratio | 2.91 | Debt to equity | 0.06 |
| 52w Index | 60.4 % | Qtr Profit Var | -3.54 % | EPS | 18.5 ₹ | Industry PE | 45.6 |
MEDANTA shows moderate fundamentals with ROCE (17.1%) and ROE (13.2%), supported by a debt-to-equity ratio of 0.06. The current price (₹1,258) is above both the 50 DMA (₹1,188) and 200 DMA (₹1,178), indicating bullish momentum. RSI at 60.7 suggests nearing overbought territory, while MACD at 17.4 confirms positive momentum. Volume is slightly above the weekly average, reflecting active participation. However, valuation is stretched with a P/E of 68.2 compared to industry average of 45.6, and PEG ratio of 2.91 indicates expensive growth. Overall, MEDANTA is a cautious swing trade candidate with limited upside.
🎯 Optimal Entry Price
Entry around ₹1,220–1,240 is favorable, aligning with support near the 50 DMA.
📈 Exit Strategy
If already holding, consider exiting near ₹1,350–1,380 (resistance zone). A strict stop-loss below ₹1,200 is advisable to manage risk.
✅ Positive
- 📌 Trading above both 50 DMA and 200 DMA, confirming bullish momentum.
- 📌 EPS of ₹18.5 supports earnings consistency.
- 📌 DII holdings increased (+0.77%), showing domestic institutional confidence.
- 📌 PAT growth from ₹107 Cr. to ₹124 Cr. indicates earnings momentum.
⚠️ Limitation
- 📌 High P/E (68.2) compared to industry average (45.6) suggests overvaluation.
- 📌 PEG ratio of 2.91 indicates expensive growth.
- 📌 RSI at 60.7 signals nearing overbought territory.
- 📌 FII holdings decreased (-0.39%), showing reduced foreign investor confidence.
- 📌 Dividend yield is very low (0.04%).
📰 Company Negative News
- 📌 No major negative news reported, but valuation concerns persist.
🌟 Company Positive News
- 📌 Strong quarterly PAT growth and improved EPS.
- 📌 Domestic institutional investors increasing stake shows confidence in long-term performance.
🏭 Industry
- 📌 Industry P/E of 45.6 is lower than MEDANTA’s 68.2, suggesting relative overvaluation.
- 📌 Healthcare sector remains resilient with consistent demand.
🔎 Conclusion
MEDANTA is fundamentally decent but technically overvalued. It is a cautious swing trade candidate with entry near ₹1,220–1,240 and exit around ₹1,350–1,380. A strict stop-loss below ₹1,200 is essential to manage risk effectively.
Would you like me to extend this with a sector overlay comparison or a peer benchmarking analysis to contextualize MEDANTA’s swing trade outlook?